Challenging Alzheimer's: Korean Firms Forge Ahead In Multiple Modalities

Hopes RIse As Diverse Contenders Enter Late-Stage Trials

In Vivo takes an infographic look at where South Korea stands in the development of a wide-ranging set of drugs for Alzheimer’s disease and which companies are still in the challenging race.

tunnel
Will There Be Light After A Long Tunnel? • Source: Shutterstock

More from Global Vision

More from In Vivo